TRPV4 and Hydrocephalus: Our goal is to provide a preclinical basis for consideration of TRPV4 as a potential drug target in the treatment of hydrocephalus, and the efficacy of TRPV4 antagonists in a genetic model of the disease represents an initial step toward that goal.